公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2021 | Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer | Yoshino T.; Argil?s G.; Oki E.; Martinelli E.; Taniguchi H.; Arnold D.; Mishima S.; Li Y.; Smruti B.K.; Ahn J.B.; Faud I.; Chee C.E.; KUN-HUEI YEH ; Lin P.-C.; Chua C.; Hasbullah H.H.; Lee M.A.; Sharma A.; Sun Y.; Curigliano G.; Bando H.; Lordick F.; Yamanaka T.; Tabernero J.; Baba E.; Cervantes A.; Ohtsu A.; Peters S.; Ishioka C.; Pentheroudakis G. | Annals of Oncology | 39 | 36 | |
2020 | Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS | Park K.; Vansteenkiste J.; Lee K.H.; Pentheroudakis G.; Zhou C.; Prabhash K.; Seto T.; Voon P.J.; Tan D.S.W.; CHIH-HSIN YANG ; Wang J.; Babu K.G.; Nakayama Y.; Alip A.; Chua K.L.M.; CHIA-HSIEN CHENG ; Senan S.; Ahn Y.C.; Kim T.-Y.; Ahn H.K.; Peters S.; Yoshino T.; Douillard J.-Y. | Annals of Oncology | 66 | 58 | |
2020 | Pembrolizumab or placebo plus etoposide and platinum as first-line therapy for extensive-stage small-cell lung cancer: Randomized, double-blind, phase III KEYNOTE-604 Study | Rudin C.M.; Awad M.M.; Navarro A.; Gottfried M.; Peters S.; Csoszi T.; Cheema P.K.; Rodriguez-Abreu D.; Wollner M.; CHIH-HSIN YANG ; Mazieres J.; Orlandi F.J.; Luft A.; G?m?? M.; Kato T.; Kalemkerian G.P.; Luo Y.; Ebiana V.; Pietanza M.C.; Kim H.R.; KEYNOTE-604 Investigators | Journal of Clinical Oncology | 389 | 303 |